What is the current stock price of Regnum Corp. (RGMP)?

As of the latest market data, Regnum Corp. (RGMP) is trading at $0.00. The stock has seen a loss of 0.00% today.

Does Regnum Corp. (RGMP) pay a dividend?

Based on current data, Regnum Corp. does not have a confirmed active dividend policy.

What is the market cap of Regnum Corp.?

The current market capitalization of Regnum Corp. (RGMP) is approximately unavailable.

RGMP

Regnum Corp.·Healthcare

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.00

Company Profile

Regnum Corp. develops and commercializes therapeutics that treat rare and infectious diseases. It develops Leronlimab (PRO 140), a monoclonal antibody C—C chemokine receptor type 5 antagonist, that is designed to prevent human immunodeficiency virus from entering human cells. The company is based in New York, New York. Regnum Corp. is a subsidiary of Phoenixus AG.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2019-05-29

Beta

-0.47

Websitewww.regnumcorp.com↗